Effect of Atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events

被引：27

作者：

Gaspardone, A ^{[1
]}

Versaci, F ^{[1
]}

Proietti, I ^{[1
]}

Tomai, F ^{[1
]}

Altamura, L ^{[1
]}

Skossyreva, O ^{[1
]}

Chiariello, L ^{[1
]}

机构：

[1] Univ Roma Tor Vergata, Div Cardiochirurg, European Hosp, Cattedra Cardiochirurg, I-00149 Rome, Italy

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 07期

关键词：

D O I：

10.1016/S0002-9149(02)02615-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A high dose of atorvastatin initiated at the time. of coronary artery stent implantation reduced the acute systemic inflammatory response and the incidence of clinical events at 6-month follow-up to levels comparable to those observed in patients treated with statins for >6 months before the procedure.

引用

收藏

页码：786 / +

页数：5

相关论文

共 20 条

[1] HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis [J].

Bustos, C ;

Hernández-Presa, MA ;

Ortego, M ;

Tuñón, J ;

Ortega, L ;

Pérez, F ;

Díaz, C ;

Hernández, G ;

Egido, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :2057-2064

[2] Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention [J].

Chan, AW ;

Bhatt, DL ;

Chew, DP ;

Quinn, MJ ;

Moliterno, DJ ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2002, 105 (06) :691-696

[3] Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention [J].

Chew, DP ;

Bhatt, DL ;

Robbins, MA ;

Penn, MS ;

Schneider, JP ;

Lauer, MS ;

Topol, EJ ;

Ellis, SG .

CIRCULATION, 2001, 104 (09) :992-997

[4] Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations [J].

Flaker, GC ;

Warnica, JW ;

Sacks, FM ;

Moyé, LA ;

Davis, BR ;

Rouleau, JL ;

Webel, RR ;

Pfeffer, MA ;

Braunwald, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :106-112

[5]

Gaspardone A, 2001, Ital Heart J, V2, P848

[6] Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina [J].

Gaspardone, A ;

Crea, F ;

Versaci, F ;

Tomai, F ;

Pellegrino, A ;

Chiariello, L ;

Gioffrè, PA .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) :515-+

[7] INTERFERON BETA-2/B-CELL STIMULATORY FACTOR TYPE-2 SHARES IDENTITY WITH MONOCYTE-DERIVED HEPATOCYTE-STIMULATING FACTOR AND REGULATES THE MAJOR ACUTE PHASE PROTEIN RESPONSE IN LIVER-CELLS [J].

GAULDIE, J ;

RICHARDS, C ;

HARNISH, D ;

LANSDORP, P ;

BAUMANN, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7251-7255

[8] Patterns and mechanisms of in-stent restenosis - A serial intravascular ultrasound study [J].

Hoffmann, R ;

Mintz, GS ;

Dussaillant, GR ;

Popma, JJ ;

Pichard, AD ;

Satler, LF ;

Kent, KM ;

Griffin, J ;

Leon, MB .

CIRCULATION, 1996, 94 (06) :1247-1254

[9] Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease [J].

Horne, BD ;

Muhlestein, JB ;

Carlquist, JF ;

Bair, TL ;

Madsen, TE ;

Hart, NI ;

Anderson, JL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1774-1780

[10]

HYAFNER G, 1995, CLIN LAB, V41, P743